Cargando…

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis

Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharya, Debapriya, Dwivedi, Ved Prakash, Maiga, Mamoudou, Maiga, Mariama, Van Kaer, Luc, Bishai, William R., Das, Gobardhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047417/ https://www.ncbi.nlm.nih.gov/pubmed/24711459 http://dx.doi.org/10.1074/jbc.M114.558098

Ejemplares similares

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity
por: Singh, Yogesh, et al.
Publicado: (2013)

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner
por: Chatterjee, Samit, et al.
Publicado: (2011)

Reply to Levis and Rendini
por: Singh, Dhiraj Kumar, et al.
Publicado: (2017)

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

In Vitro and In Vivo Studies of a Rapid and Selective Breath Test for Tuberculosis Based upon Mycobacterial CO Dehydrogenase
por: Maiga, Mamoudou, et al.
Publicado: (2014)

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
por: Devi, Annu, et al.
Publicado: (2023)

Erratum to “Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis” [EBioMedicine 2 (8), August 2015, 868–873]
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Current tuberculosis diagnostic tools & role of urease breath test
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments
por: Larsson, Christer, et al.
Publicado: (2012)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams
por: Lun, Shichun, et al.
Publicado: (2014)

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2020)

Correction: Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

The Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in Macrophages
por: Dwivedi, Ved P., et al.
Publicado: (2017)

Mycobacterium tuberculosis Subverts the TLR-2 - MyD88 Pathway to Facilitate Its Translocation into the Cytosol
por: Rahman, Md. Aejazur, et al.
Publicado: (2014)

Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells
por: Ahmad, Shaheer, et al.
Publicado: (2020)

Mycobacterium tuberculosis Beijing Strain, Bamako, Mali
por: Diarra, Bassirou, et al.
Publicado: (2010)

T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
por: Tousif, Sultan, et al.
Publicado: (2011)

CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation
por: Khan, Mohd Moin, et al.
Publicado: (2012)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022)

Expression of the ARPC4 Subunit of Human Arp2/3 Severely Affects Mycobacterium tuberculosis Growth and Suppresses Immunogenic Response in Murine Macrophages
por: Ghosh, Anamika, et al.
Publicado: (2013)

Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota
por: Namasivayam, Sivaranjani, et al.
Publicado: (2020)

The role of the microbiome in inflammation during tuberculosis
por: Somboro, Anou M., et al.
Publicado: (2021)

Association of Mycobacterium africanum Infection with Slower Disease Progression Compared with Mycobacterium tuberculosis in Malian Patients with Tuberculosis
por: Baya, Bocar, et al.
Publicado: (2020)

Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
por: Tousif, Sultan, et al.
Publicado: (2017)

Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali
por: Diarra, Bassirou, et al.
Publicado: (2018)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Prevalence and Clinical Relevance of Schistosoma mansoni Co-Infection with Mycobacterium tuberculosis: A Systematic Literature Review
por: Baya, Bocar, et al.
Publicado: (2023)

Pivotal roles of CD8(+) T cells restricted by MHC class I–like molecules in autoimmune diseases
por: Das, Gobardhan, et al.
Publicado: (2006)

Recurrent Episodes of Some Mosquito-Borne Viral Diseases in Nigeria: A Systematic Review and Meta-Analysis
por: Onoja, Anyebe Bernard, et al.
Publicado: (2022)

Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
por: Kumari, Anjna, et al.
Publicado: (2023)

Prostanoid Receptor 2 Signaling Protects T Helper 2 Cells from BALB/c Mice against Activation-induced Cell Death
por: Kaul, Vandana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ldn4r2tab0uh921kbk3jri0vf1